Sofosbuvir-velpatasvir

Epclusa

Brand for: Sofosbuvir-velpatasvir

CVS logo
CVS
$8,114.56
Albertsons logo
Albertsons
Pay Online$7,799.35
Walgreens logo
Walgreens
$7,928.12
Walmart logo
Walmart
$8,311.50
Show this card to your pharmacist

Epclusa Savings card

$7,799.35

BIN
019876
ID
LHB6CB82CC
PCN
CHIPPO
GRP
LHX

Print or send this coupon to your phone

or, if you have commercial insurance

Pay as little as $0 for Epclusa

Works with your insurance. Enroll in the manufacturer's savings program in a few steps.

Get savings card

About Epclusa

Drug Details

Epclusa is a medication combining sofosbuvir and velpatasvir, used to treat chronic hepatitis C in both adults and children. This condition is a long-term viral infection affecting the liver, which can lead to serious issues like liver scarring (cirrhosis) or liver cancer. The medication works by containing two antiviral agents that prevent the hepatitis C virus from replicating in the body. By reducing the virus levels, Epclusa aids your immune system in fighting the infection and supports liver recovery. While effective in treating the infection, it is not confirmed whether Epclusa prevents the transmission of the virus to others. Therefore, it is advised to avoid sharing needles and to practice safer sex, including using latex condoms, to minimize the risk of spreading the virus. Always consult healthcare professionals such as your doctor, nurse, or pharmacist before starting any new medication.

Price history for Epclusa (brand) & Sofosbuvir-velpatasvir (generic)

28 Tablets, 400-100MG

Average retail price for Epclusa

Average retail price for Sofosbuvir-velpatasvir

Average SaveHealth price for Sofosbuvir-velpatasvir

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

Over the last 12 months, the average discount price of Epclusa is $8083.80 using the SaveHealth savings card. That's an average savings of 72.97% on Epclusa with our discount card.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Related Prescriptions

Epclusa (Sofosbuvir-velpatasvir) dosage forms

DosageQuantityPrice fromPer unit
400-100MG28 Tablets$7,799.35$278.55

Epclusa FAQs

Epclusa is an antiviral medication used to treat chronic hepatitis C infection. It works by reducing the amount of hepatitis C virus in the body, which helps the immune system fight the infection and can lead to the virus being cleared from the body. This can prevent liver damage, cirrhosis, and liver cancer.

The cost of a 12-week course of Epclusa can vary significantly depending on factors such as location, insurance coverage, and pharmacy pricing. Without insurance, the list price for Epclusa is typically around $74,760 for a 12-week supply. However, patients are encouraged to check with their insurance provider or pharmacy for specific pricing and potential financial assistance programs that may be available to help reduce the cost.

It is generally advised to avoid alcohol while taking Epclusa. Alcohol can increase the risk of liver damage, which is a concern for individuals being treated for hepatitis C. It is important to follow the healthcare provider's recommendations and discuss any alcohol consumption with them to ensure safe and effective treatment.

Epclusa has a high success rate, with clinical trials showing a sustained virologic response (SVR) rate of approximately 95% to 99% in patients with chronic hepatitis C, across all genotypes. This means that the majority of patients achieve a cure, defined as having no detectable hepatitis C virus in the blood 12 weeks after completing treatment.

Epclusa, a medication used to treat hepatitis C, may cause some side effects related to the eyes. These can include blurred vision and dry eyes. If any eye-related side effects are experienced, it is important to consult a healthcare provider for further evaluation and management.

Read All FAQs